Intraindividual variability of reaction time (IIVRT), a proposed cognitive marker of neurobiological disturbance, increases in old age, and has been associated with dementia and mortality. The extent to which IIVRT is an independent predictor of mortality, however, is unclear. This study investigated the association of IIVRT and all-cause mortality while accounting for cognitive level, incident dementia and biomedical risk factors in 861 participants aged 70–90 from the Sydney Memory and Ageing Study. Participants completed two computerised reaction time (RT) tasks (76 trials in total) at baseline, and comprehensive medical and neuropsychological assessments every 2 years. Composite RT measures were derived from the two tasks—the mean RT and the IIVRT measure computed from the intraindividual standard deviation of the RTs (with age and time-on-task effects partialled out). Consensus dementia diagnoses were made by an expert panel of clinicians using clinical criteria, and mortality data were obtained from a state registry. Cox proportional hazards models estimated the association of IIVRT and mean RT with survival time over 8 years during which 191 (22.2%) participants died. Greater IIVRT but not mean RT significantly predicted survival time after adjusting for age, sex, global cognition score, cardiovascular risk index and apolipoprotein ɛ4 status. After excluding incident dementia cases, the association of IIVRT with mortality changed very little. Our findings suggest that greater IIVRT uniquely predicts shorter time to death and that lower global cognition and prodromal dementia in older individuals do not explain this relationship.
Citation: Kochan NA, Bunce D, Pont S, Crawford JD, Brodaty H, Sachdev PS (2017) Is intraindividual reaction time variability an independent cognitive predictor of mortality in old age? Findings from the Sydney Memory and Ageing Study. PLoS ONE 12(8): e0181719. https://doi.org/10.1371/journal.pone.0181719
Editor: Stephen D. Ginsberg, Nathan S Kline Institute, UNITED STATES
Received: February 21, 2017; Accepted: July 6, 2017; Published: August 9, 2017
Copyright: © 2017 Kochan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Data may be available to interested researchers upon request to the Sydney Memory and Ageing Study (MAS) Governance Committee (via email: firstname.lastname@example.org). This is required because of the conditions of the MAS ethics approval and the consent forms which only allows data to be passed onto third parties following review and approval by the study governance committee.
Funding: Funded by National Health and Medical Research Council of Australia Program Grant (grant number 350833) (HB PS), National Health and Medical Research Council of Australia Early Career Fellowship (grant number 123148) (NK), and Dementia Collaborative Research Centre (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
In addition to average performance level, there is an increasing focus in ageing research on intraindividual variability or inconsistency in cognitive performance. Such variability in performance is often measured by the trial-to-trial within-person variation in reaction times (RT) on a single cognitive task and is known as intraindividual reaction time variability (IIVRT). IIVRT has received considerable attention as a useful indicator of neurobiological disturbance . Consistent with this, several studies indicate that IIVRT is greater in older age  and in a variety of neuropathological conditions of old age including mild cognitive impairment , dementia  and Parkinson’s disease . Additionally, associations have been found with measures of brain integrity, including white matter hyperintensities , brain connectivity , and dopaminergic neuromodulation .
Our present interest is whether this measure can predict mortality in old age. It is possible that neurobiogical changes that are related to eventual mortality are captured by variability measures and are present many years in advance. A few studies have reported that increased variability predicts mortality up to 19 years before eventual death in older populations [9–11] but it is unknown whether this association is independent of general age-related cognitive decline, an established risk factor for mortality [12, 13]. Moreover, the potential influence of incipient dementia on this relationship  has not been addressed adequately in previous studies that have used unreliable means of case identification (e.g., ‘questionable dementia’ written on death certificates , dementia screening measures with low sensitivity , or have not attempted to remove dementia cases ). There is preliminary support for the relative importance of IIVRT as a predictor of mortality over the more basic measure of mean RT from the same cognitive task [9, 10] and this is worthy of further investigation particularly in the context of the potential influence of global cognitive level and prodromal dementia on these relationships.
Hence, IIVRT warrants investigation as a specific predictor of impending death in older age independently of global cognitive level, other mortality risk factors and speed (mean RT from the same task) and prodromal dementia using robust clinical diagnoses in the years before death. Therefore, the aim of this study was to investigate the association of IIVRT with mortality over 8 years in a large, well-characterised population-based cohort of older adults aged 70 years and over, taking into account general cognitive function as assessed by a battery of psychometric tests, other mortality risk factors including demographics, cardiovascular risk and apolioprotein ɛ4 status, and dementia diagnosis based on DSM-IV .
Materials and methods
Participants were drawn from the Sydney Memory and Ageing Study (MAS), a longitudinal study of community dwelling older adults recruited through the Australian electoral roll, aged 70 to 90 years at baseline . Wave 1 MAS participants were recruited from September 2005 to November 2007. Exclusionary criteria were as follows: Mini-Mental State Score (MMSE) ≤ 24  adjusted for age and education , or baseline diagnosis of dementia, schizophrenia, bipolar disorder, multiple sclerosis, motor neuron disease, developmental disability, and progressive malignancy. Of the remaining 1037 participants at baseline, we excluded 164 participants of non-English speaking background because validity of cognitive test performance for this group is questionable [19, 20], and 12 participants without RT data, leaving 861 for the the study sample. The study was approved by the Human Research Ethics Committees of the University of New South Wales and South East Sydney and Illawarra Area Health Service. Participants gave written informed consent.
Reaction time measures
Simple and complex RT tasks were administered at baseline on a touch screen computer with millisecond accuracy . For the simple RT task, participants had to touch a yellow square as quickly as possible, presented at 1, 2 or 4 second interstimulus intervals over a total of 36 trials over 2 blocks. For the complex RT, two coloured squares appeared vertically (red-red, yellow-yellow, red-yellow, yellow-red) at 3-second interstimulus intervals over a total of 40 trials over 2 blocks. Participants had to touch the upper square if the squares were the same colour or the lower square if the squares were different in colour. Practice trials prior to testing ensured that participants achieved four consecutive correct trials before they were allowed to continue. Processing of RT data and computation of metrics followed established procedures [21, 22]. For the IIVRT measure, intraindividual standard deviation (SD) of RTs were computed using a regression procedure that partialled out effects of time-on-task (trial order) and age (and their interaction) from the individual RTs. The residuals obtained were then standardised and converted into T-scores, and finally an estimate of each individual’s standard deviation across the trials was computed. Mean RT was also computed. To obtain the most reliable estimates, linear-weighted composite scores for mean RT and IIVRT were computed from the two RT tasks (Simple and Complex).
Clinical and cognitive measures
Comprehensive assessments consisting of medical history, medical examination, neuropsychological measures and informant interviews were conducted by trained research psychologists at two-yearly intervals. Participants completed a battery of 10 psychometric tests measuring five major cognitive domains: attention/processing speed (Digit Symbol-Coding, Trail Making Test A), memory (Rey Auditory Verbal Learning Test, Logical Memory, Benton Visual Retention Test), language (Boston Naming Test, Category Fluency Test), visuospatial (Block Design) and executive abilities (Trail Making Test B, Letter Fluency Test), details of which have been previously published [16, 19]. Participants received the neuropsychological battery at each wave they were present (ranging from 1–4 occasions) unless they were deemed too cognitively impaired (from wave 2 onward) in which case they were administered the Addenbrooke’s Cognitive Examination-Revised .
Wave 1 neuropsychological test data were used in the analyses. Raw scores were transformed to z-scores using baseline means and SDs of a subgroup of cognitively normal individuals. A global cognition score was calculated by averaging z-scores and transforming this so that the normal subgroup mean equals 0 and SD equals 1 (a higher score represents better performance). This cognitive composite score was used as a covariate in analyses to control for the known association of cognitive level with mortality . The MMSE  and the National Adult Reading Test-Revised  were administered to measure current cognitive level and premorbid cognitive level respectively.
Other covariates previously linked to mortality included apolipoprotein ɛ4 (ApoE ɛ4) status  and cardiovascular disease risk , as well as age and sex. ApoE genotyping was obtained from genomic DNA extracted from peripheral blood or saliva  and ɛ4 carriers were compared to non-carriers (one or two ɛ4 alleles versus none). A cardiovascular disease risk score based on the Framingham Study  was derived from age, current smoking status, diabetic status, systolic blood pressure, total cholesterol level, high density lipoprotein level, and current hypertensive medication.
Dementia and vital status ascertainment
At each study wave, cases were reviewed at case conference to reach a consensus on dementia diagnosis by a minimum of three clinicians from an expert multidisciplinary panel comprising of old age psychiatrists, neuropsychiatrists and clinical neuropsychologists. Dementia was diagnosed using DSM-IVcriteria  using all available clinical information, neuropsychological scores, and MRI when available (approximately half the sample) . Vital status of participants, and cause and date of death were obtained from the New South Wales Registry of Births, Deaths and Marriages for 8 years after the study commenced.
Analyses were performed using IBM SPSS Statistics 22.0. Baseline characteristics for deceased and surviving participants were compared using Chi-square for categorical variables, and Student’s t-test for continuous variables with the exception of the RT measures which were assessed using non-parametric tests (Mann-Whitney) as these variables were skewed. Bivariate correlations were assessed using Pearson’s correlations or Spearman’s for correlations between RT measures and other variables. Cox proportional-hazards models were used to examine the effects of baseline mean RT and IIVRT on hazard rates of all-cause mortality. Time to event was computed as the number of years and months between each individual’s baseline assessment and a) date of death for decedents or b) the last assessment date for which surviving participants were known to be alive up to the end of the study period (July 2014). All survivors were included in the Cox analyses as right-censored. Mean RT and IIVRT measures were transformed to z scores. Each RT measure was entered into separate models. The models were estimated without covariates (Model 1), then with covariates (e.g., age, sex, global cognition score, cardiovascular disease index, ApoE ɛ4 status) (Model2) and finally, a backward regression procedure was used with both RT measures included and all covariates to determine the best predictors of mortality (Model 3). All analyses were repeated after excluding incident dementia cases diagnosed over the 8-year period along with additional cases where dementia was listed as a cause of death on the Death Certificate.
Sample baseline characteristics based on vital status are shown in Table 1. Of 861 participants, 191 died (22.2%) within 8 years of follow-up with a mean survival time of 4.3 years (SD = 2.2). Decedants had significantly slower mean RT and greater IIVRT, lower general cognitive ability and a higher CVD risk score, and were older and more likely to be male than those who survived. Table 2 displays bivariate correlations between the main variables.
In unadjusted Cox models, greater IIVRT and slower mean RT were both individually associated with all-cause mortality (Table 3. Model 1: IIVRT left side; Mean RT right side). The effect sizes were comparable for the two measures; the hazard was raised by approximately 35% for a 1 SD increase in variability or mean RT. However, in separate multivariable Cox regression models adjusting for global cognition and the other covariates (i.e., age, sex, APOE ɛ4 status, cardiovascular risk score), IIVRT remained significant but mean RT did not reach significance (Table 3. Model 2: IIVRT left side; Mean RT right side). When both measures were entered together in a basic regression model adjusted for age and sex, the effects were considerably attenuated (mean RT: Wald = 1.58 HR = 1.12 (95%CI: .94–1.31) p = .21; IIVRT: Wald = 1.42 HR = 1.15 (95%CI: .91–1.44) p = .23), indicating that the respective variables did not contribute uniquely above the other. A similar result was obtained when the remaining covariates were included in the model. This was not unexpected given the strong correlation of .67 between the two measures (see Table 2). To determine the best set of independent predictors, backward elimination was used from the fully adjusted model, with IIVRT, mean RT and all covariates entered at the first step (Table 3: Model 3). In this final model, IIVRT, age, sex and cognition were retained as the most parsimonious set of predictors of all-cause mortality, noting that cognition was not a significant independent predictor in the model.
Next, in order to account for the potential effects of dementia pathology on the associations of RT measures and mortality, we evaluated the determinants of survival in persons free of dementia. Over the 8-year study period, 82 individuals from our initial cohort of dementia-free elders, received a consensus diagnosis of dementia from the expert panel. Three further participants with evidence of cognitive impairment while in the study and dementia listed as the cause of death on death certificates were also classified as incident dementia cases. Altogether 29 of 191 of decedents (15.2%) had a dementia diagnosis. Separate multivariable Cox regression analyses were repeated after removing these 85 participants with incident dementia from the baseline cohort (N = 708; 144 deceased). The predictive strengths of the RT measures were virtually unchanged though neither attained conventional significance level after accounting for all risk factors (mean RT: Wald = 2.84 HR = 1.20 (.97–1.48) p = .09; IIVRT: Wald = 2.84 HR = 1.20 (.97–1.47) p = .09); age and sex were the only significant predictors in both RT models. Repeating the backward regression after eliminating dementia cases, with both RT measures and all covariates entered at the first step, IIVRT remained a significant predictor in the final model along with age and sex (IIVRT: Wald = 3.89 HR = 1.23 (95%CI: 1.00–1.50) p = .049), global cognition was excluded. Additional data for full models with dementia cases excluded are provided in S1 Table.
In this large community-based old age cohort, greater variability in RT performance but not slower mean RT predicted all-cause mortality while adjusting for conventional mortality risk factors of age, sex, cardiovascular risk and APOE ɛ4 status and important potential confounders of low global cognition and prodromal dementia, both known to be associated with greater IIVRT [4, 35] and increased mortality risk in old age [12, 13, 36]. Following removal of known incident dementia cases, the association between IIVRT and time to death in the multivariable model decreased slightly and failed to reach significance. However, the findings remained robust in the most parsimonious model even after dementia cases were removed with greater IIVRT, older age and male sex significant predictors of all-cause mortality.
Our findings broadly support and extend the small extant literature [9–11, 37] by providing further support for a strong association between IIVRT and all-cause mortality having adjusted for a broad range of potential confounders. Previous studies have failed to adequately account for effects of overall cognitive level and dementia on the relationship between IIVRT and mortality. Of the few studies that have included measures of cognition, investigators have simply controlled for performance accuracy on the individual tasks from which RT data were taken , or compared RT measures with one or two other cognitive measures (e.g., memory, visuospatial reasoning). The global cognition score employed in the present study is a more reliable and valid measure of cognition than those previously used since it is based on a large number of psychometrically validated cognitive tasks and it measures five major cognitive domains thereby more broadly capturing the individual’s level of cognitive function.
Dementia was also considered a potential confound in light of our previous work showing that incident dementia is associated with worse performance on cognitive measures, and IIVRT and mean RT  and reduced survival time . While no MAS participant had dementia at baseline, 85 were found to have dementia on biennial assessments over the 8-year follow-up period. After removal of these 85 incident dementia cases, the effect strength was slightly reduced (IIVRT: HR from 1.22 to 1.20) and failed to reach significance at conventional levels in the full model (p = .09), possibly because of the smaller sample size and loss of power, and higher variability scores in those who later developed dementia. However, when the model was refined by removing non-significant covariates, IIVRT was retained in the set of best predictors, along with age and sex. Our findings suggest therefore that prodromal dementia does not explain the association of IIVRT and time to death and address the shortcomings of previous studies that have either not considered dementia, even in the oldest-old when risk of dementia is very high ([e.g. 11], whose participants were aged up to 94), or have used less rigorous methods of controlling for dementia. For example, MacDonald and colleagues  relied solely on death certificates which listed “questionable dementia” as an antecedent condition (not primary cause) of death and reported “identical patterns of inference” with and without 33 cases of questionable dementia (12.5% of decedents). Batterham et al  used a cut-score of ≤24 on the MMSE to control for possible preclinical dementia. However, conclusions about the effects of dementia on the IIVRT-mortality relationship were limited by the low positive predictive value of the MMSE for dementia in population studies  and its crude measurement of global cognition compared to a neuropsychological battery and clinical consensus such as that used in the present study which is the gold standard for dementia diagnosis.
There is preliminary support for a stronger relationship of mortality with variability measures over mean RT measures when examined together [9, 10] although this is not universal across studies  or cognitive tasks [9, 10]. In our study, mortality effects were attenuated when both measures were included in the same base model and neither of the RT measures was an independendent predictor over the other. This may not be surprising given the strong correlation between the measures; increased IIVRT may be reflecting a higher number of slow responses would also give rise to a slower mean RT. Furthermore, there is a part-whole association between IIVRT and mean performance given that IIVRT scores reflect residual variance after controlling for age-group and time on task (trial order) while mean RT includes all sources of variability . However, it is noteworthy that IIVRT was more weakly correlated with the global cognition score (r = -.26) relative to that of mean RT (r = -.50) supporting the premise that IIVRT is capturing unique information relating to mortality that other cognitive measures are not tapping. From a cognitive perspective, increased IIVRT is thought to reflect a) momentary fluctuations in attentional and executive control [40, 41]; b) individual differences in the rate at which task-related information accumulates to reach a critical threshold before triggering a response  or c) increased neural noise as the signal to noise ratio in the brain decreases. The consequence in behavioural terms is increased variation in moment-to-moment processing efficiency uniquely captured by IIVRT measures.
The present study suggests that variability from performance-based measures of reaction time is an independent risk factor and not simply a corollary of general cognitive decline or neuropathological disturbances associated with dementia. Therefore, other explanatory mechanisms for the relationship between within-person variability and mortality should be considered. At the neurobiological level, research suggesting the involvement of striatal dopamine D2 receptor binding in IIVRT  is consistent with the theory that IIVRT may reflect increased neural noise. Specifically, it has been postulated that neural noise increases with age as a result of reduced efficiency of the central nervous system and alterations in neurotransmitter systems (e.g., dopaminergic system) leading to more erratic processing which is captured by IIVRT measures . This neurobiological disturbance may become further exaggerated closer to death .
However, it is also possible that behavioural variability is a proxy measure of general age-related deterioration of physiological (body) processes. A deteriorating brain may simply be a part of a deteriorating body  as suggested by the “common cause” hypothesis of cognitive ageing  which delineates a single ageing process in physical and cognitive functions. Our study suggests that estimating variability from reaction time measures is a more sensitive indicator of survival than estimating mean levels of performance across several performance-based measures of reaction time and other cognitive domains although all are indicators of a degenerating brain. This does not necessarily argue against a common cause since different parts of the brain may react differentially, for example the hippocampus is more sensitive to hypoxia. Likewise, the frontal cortex is more vulnerable to aging processes  and this may underlie the sensitivity of IIVRT measures to impending mortality. Future research using a multimodal approach incorporating cognitive and physical measures, and imaging to examine trajectories of intra-individual variability, physical frailty and neurodegeneration, and their associations with mortality in old age, may shed light on the common cause hypothesis.
Limitations of the research should be considered. The primary focus of our study was on cognition and inclusion of a comprehensive set of potential predictors of mortality is beyond the scope of this study. The selection of variables for the current study was based on the most commonly examined in the literature. In a recent publication, our group has examined a comprehensive range of risk factors for mortality, and also for dementia and Mild Cognitive Impairment . We identified 85 cases with dementia over the follow-up period corresponding to an incidence rate of 19.1/1000 person-years in this older adult community sample. Although this is in line with published rates globally [47, 48], some cases of dementia may not have been detected before death. There are several reasons for this. First, the study design used 2-year assessment intervals and conversion to dementia may have occurred after the last assessment but before death. Second, a common issue in longitudinal studies is the problem of attrition and persons who drop out of observational cohort studies have an increased likelihood of progression to dementia . Third, in Australia we do not have access to a dementia registry, which may have allowed more complete identification of new dementia cases. Given these considerations, we may have underestimated the effects of dementia on the association of mortality and IIVRT. Despite these limitations, the present study represents the most rigorous attempt to date to control for general cognitive level and dementia, and also major risk factors using comprehensive assessments and diagnoses based on clinical criteria. Nonetheless, it is important that future research address the possibility of dementia and other risk factors affecting the association of IIVRT and mortality.
In conclusion, the present study suggests that variability of RT represents a unique cognitive marker of impending death beyond an individual’s overall cognitive function and various other risk factors. Accounting for new cases of dementia up to 8 years after the baseline assessment did not alter the IIVRT-mortality association suggesting that this association is independent of dementia-related neuropathological changes in the prodromal period. The findings supports the view of IIVRT as a behavioural marker of neurobiological integrity  and that this may underlie its sensitivity to terminal decline and death, as well as other neuropathological states such as dementia , and falls risk .
The authors thank all participants and their supporters in the Sydney Memory and Ageing Study (MAS), and the MAS research team.
- 1. Hultsch DF, Strauss E, Hunter MA, MacDonald SWS. Intraindividual variability, cognition and aging. In: Craik FIM, Salthouse TA, editors. The handbook of aging and cognition. 3rd ed. New York: Psychology Press; 2008. p. 491–556.
- 2. Bielak AA, Cherbuin N, Bunce D, Anstey KJ. Intraindividual variability is a fundamental phenomenon of aging: evidence from an 8-year longitudinal study across young, middle, and older adulthood. Dev Psychol. 2014;50(1):143–51. pmid:23586940.
- 3. Bielak AAM, Hultsch DF, Strauss E, MacDonald SWS, Hunter MA. Intraindividual variability in reaction time predicts cognitive outcomes 5 years later. Neuropsychology. 2010;24(6):731–41. pmid:20853957.
- 4. Hultsch DF, MacDonald SW, Hunter MA, Levy-Bencheton J, Strauss E. Intraindividual variability in cognitive performance in older adults: comparison of adults with mild dementia, adults with arthritis, and healthy adults. Neuropsychology. 2000;14(4):588–98. pmid:11055261.
- 5. de Frias CM, Dixon RA, Fisher N, Camicioli R. Intraindividual variability in neurocognitive speed: a comparison of Parkinson's disease and normal older adults. Neuropsychologia. 2007;45(11):2499–507. pmid:17507058.
- 6. Bunce D, Anstey KJ, Christensen H, Dear K, Wen W, Sachdev P. White matter hyperintensities and within-person variability in community-dwelling adults aged 60–64 years. Neuropsychologia. 2007;45(9):2009–15. pmid:17382358.
- 7. Deary IJ, Bastin ME, Pattie A, Clayden JD, Whalley LJ, Starr JM, et al. White matter integrity and cognition in childhood and old age. Neurology. 2006;66(4):505–12. pmid:16505302.
- 8. MacDonald SW, Cervenka S, Farde L, Nyberg L, Backman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia. 2009;47(11):2299–304. pmid:19524093.
- 9. MacDonald SW, Hultsch DF, Dixon RA. Predicting impending death: inconsistency in speed is a selective and early marker. Psychol Aging. 2008;23(3):595–607. PubMed Central PMCID: PMCNIHMS48793 PMC2562863. pmid:18808249
- 10. Batterham PJ, Bunce D, Mackinnon AJ, Christensen H. Intra-individual reaction time variability and all-cause mortality over 17 years: a community-based cohort study. Age Ageing. 2014;43(1):84–90. pmid:23934546.
- 11. Shipley BA, Der G, Taylor MD, Deary IJ. Association between mortality and cognitive change over 7 years in a large representative sample of UK residents. Psychosom Med. 2007;69(7):640–50. pmid:17846257.
- 12. Connors MH, Sachdev PS, Kochan NA, Xu J, Draper B, Brodaty H. Cognition and mortality in older people: The Sydney Memory and Ageing Study. Age Ageing. 2015;44(6):1049–54. pmid:26504121
- 13. Perna L, Wahl H-W, Mons U, Saum K-U, Holleczek B, Brenner H. Cognitive impairment, all-cause and cause-specific mortality among non-demented older adults. Age Ageing. 2015;44(3):445–51. pmid:25468013
- 14. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry. 2001;16(8):751–61. pmid:11536341.
- 15. APA. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
- 16. Sachdev PS, Brodaty H, Reppermund S, Kochan NA, Trollor JN, Draper B, et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70–90 years. International Psychogeriatrics. 2010;22:1248–64. pmid:20637138
- 17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189–98. pmid:1202204.
- 18. Anderson TM, Sachdev PS, Brodaty H, Trollor JN, Andrews G. Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians. American Journal of Geriatric Psychiatry. 2007;15(6):467–76. pmid:17545447.
- 19. Kochan NA, Slavin MJ, Brodaty H, Crawford J, Trollor JN, Draper B, et al. Effect of Different Impairment Criteria on Prevalence of "Objective" Mild Cognitive Impairment in a Community Sample. American Journal of Geriatric Psychiatry. 2010;18(8):711–22. pmid:21491632
- 20. Low L, Harrison F, Kochan NA, Draper B, Slavin MJ, Reppermund S, et al. Can mild cognitive impairment be accurately diagnosed in English speakers from linguistic minorities? Results from the Sydney Memory and Ageing Study. American Journal of Geriatric Psychiatry. 2012;20(10):866–77. pmid:22261551
- 21. Kochan NA, Bunce D, Pont S, Crawford JD, Brodaty H, Sachdev PS. Reaction Time Measures Predict Incident Dementia in Community-Living Older Adults: The Sydney Memory and Ageing Study. Am J Geriatr Psychiatry. 2016;24(3):221–31. pmid:26905045
- 22. Hultsch DF, MacDonald SWS, Dixon RA. Variability in reaction time performance of younger and older adults. J Gerontol B Psychol Sci Soc Sci. 2002;57(2):P101–15. pmid:11867658.
- 23. Wechsler D. Wechsler Adult Intelligence Scale-III. San Antonio: The Psychological Corporation; 1997.
- 24. Strauss E, Sherman E, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. New York: Oxford University Press; 2006.
- 25. Wechsler D. Wechsler Memory Scale. Third edition manual. San Antonio: The Psychological Corporation; 1997.
- 26. Benton AL, Sivan AB, Spreen O. Der Benton Test. 7th ed. Bern: Huber; 1996.
- 27. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lippincott Williams & Wilkins; 2001.
- 28. Wechsler D. Wechsler Adult Intelliegence Scale—Revised. New York: Psychological Corporation; 1981.
- 29. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078–85. pmid:16977673
- 30. Nelson HE, Willison JR. National Adult Reading Test (NART): Test Manual. 2nd ed. Windsor: NFER-Nelson; 1991.
- 31. Ewbank DC. Differences in the association between apolipoprotein E genotype and mortality across populations. Journals of Gerontology Series A-Biological Sciences & Medical Sciences. 2007;62(8):899–907. pmid:17702883.
- 32. Goh LG, Welborn TA, Dhaliwal SS. Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study. BMC Women's Health. 2014;14:118. PubMed Central PMCID: PMCPMC4181599. pmid:25255986
- 33. Song F, Poljak A, Crawford J, Kochan NA, Wen W, Cameron B, et al. Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS ONE 2012;7(6):e34078. PubMed Central PMCID: PMCPMC3372509. pmid:22701550
- 34. D'Agostino RB, Ramachandran SV, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Study. Circulation. 2008;117:743–53. pmid:18212285
- 35. Bielak AAM, Hultsch DF, Strauss E, MacDonald SWS, Hunter MA. Intraindividual variability is related to cognitive change in older adults: evidence for within-person coupling. Psychol Aging. 2010;25(3):575–86. pmid:20853965.
- 36. Connors MH, Ames D, Boundy K, Clamette R, Kurrie S, Mander A, et al. Predictors of mortality in dementia: The PRIME Study. Journal of Alzheimer's Disease. 2016;52(3):967–74. pmid:27079702
- 37. Deary IJ, Der G. Reaction time explains IQ's association with death. Psychol Sci. 2005;16(1):64–9. pmid:15660853.
- 38. Brodaty H, Seeher K, Gibson L. Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. International Psychogeriatrics. 2012;24(7):1034–45. pmid:22325331
- 39. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. Journal of Psychiatric Research. 2009;43(4):411–31. pmid:18579155.
- 40. West R, Murphy KJ, Armilio ML, Craik FI, Stuss DT. Lapses of intention and performance variability reveal age-related increases in fluctuations of executive control. Brain Cogn. 2002;49(3):402–19. pmid:12139961.
- 41. Bunce D, MacDonald SW, Hultsch DF. Inconsistency in serial choice decision and motor reaction times dissociate in younger and older adults. Brain Cogn. 2004;56(3):320–7. pmid:15522770.
- 42. Schmiedek F, Oberauer K, Wilhelm O, Suss HM, Wittmann WW. Individual differences in components of reaction time distributions and their relations to working memory and intelligence. Journal of experimental psychology General. 2007;136(3):414–29. Epub 2007/08/19. pmid:17696691.
- 43. Li SC, Lindenberger U, Sikstrom S. Aging Cognition: from neuromodulation to representation. Trends Cogn Sci. 2001;5(11):479–86. pmid:11684480
- 44. Christensen H, Mackinnon AJ, Korten A, Jorm AF. The "common cause hypothesis" of cognitive aging: evidence for not only a common factor but also specific associations of age with vision and grip strength in a cross-sectional analysis. Psychol Aging. 2001;16(4):588–99. pmid:11766914.
- 45. Drag LL, Bieliauskas LA. Contemporary Review 2009: Cognitive Aging. Journal of Geriatric Psychiatry and Neurology. 2010;23(2):75–93. pmid:20101069.
- 46. Lipnicki DM, Crawford J, Kochan NA, Trollor JN, Draper B, Reppermund S, et al. Risk Factors for Mild Cognitive Impairment, Dementia and Mortality: The Sydney Memory and Ageing Study. Journal of the American Medical Directors Association. 2017;18(5):388–95. pmid:28043804
- 47. Knopman DS, Roberts RO, Pankratz VS, Cha RH, Rocca WA, Mielke MM, et al. Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. Am J Epidemiol. 2014;180(4):414–23. PubMed Central PMCID: PMCPMC4128768. pmid:24859276
- 48. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl 5):S10–5. pmid:10854355.
- 49. Jacova C, Hsiung GY, Feldman HH. Dropouts and refusals in observational studies: lessons for prevention trials. Neurology. 2006;67(9 Suppl 3):S17–20. pmid:17101929.
- 50. Graveson J, Bauermeister S, McKeown D, Bunce D. Intraindividual reaction time variability, falls and gait in old age: A systematic review. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences. 2016;71(5):857–64.